Literature DB >> 34570433

Non-Chromatographic Purification of Synthetic RNA Using Bio-Orthogonal Chemistry.

Muhan He1, Xunshen Wu1, Song Mao1, Phensinee Haruehanroengra1, Irfan Khan1, Jia Sheng1, Maksim Royzen1.   

Abstract

Solid-phase synthesis of RNA oligonucleotides over 100 nt in length remains challenging due to the complexity of purification of the target strands from the failure sequences. This article describes a non-chromatographic procedure that will enable routine solid-phase synthesis and purification of long RNA strands. The optimized five-step process is based on bio-orthogonal inverse electron demand Diels-Alder chemistry between trans-cyclooctene (TCO) and tetrazine (Tz), and entails solid-phase synthesis of RNA on a photo-labile support. The target oligonucleotide strands are selectively tagged with Tz while on-support. After photocleavage from the solid support, the target oligonucleotide strands can be captured and purified from the failure sequences using immobilized TCO. The approach can be applied for purification of 76-nt long tRNA and 101-nt long sgRNA for CRISPR experiments. Purity of the isolated oligonucleotides should be evaluated using gel electrophoresis, while functional fidelity of the sgRNA should be confirmed using CRISPR-Cas9 experiments.
© 2021 Wiley Periodicals LLC. Basic Protocol: Five-step non-chromatographic purification of synthetic RNA oligonucleotides Support Protocol 1: Synthesis of the components that are required for the non-chromatographic purification of long RNA oligonucleotides. Support Protocol 2: Solid-phase RNA synthesis. © 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  RNA; bio-orthogonal chemistry; oligonucleotide; purification; tetrazine; trans-cyclooctene

Mesh:

Substances:

Year:  2021        PMID: 34570433      PMCID: PMC8480532          DOI: 10.1002/cpz1.247

Source DB:  PubMed          Journal:  Curr Protoc        ISSN: 2691-1299


  9 in total

1.  Synthetic oligodeoxynucleotide purification by polymerization of failure sequences.

Authors:  Shiyue Fang; Suntara Fueangfung; Xi Lin; Xiang Zhang; Wenpeng Mai; Lanrong Bi; Sarah A Green
Journal:  Chem Commun (Camb)       Date:  2010-11-17       Impact factor: 6.222

2.  Purification of antisense oligonucleotides.

Authors:  R R Deshmukh; D L Cole; Y S Sanghvi
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

3.  Improved Utility of Photolabile Solid Phase Synthesis Supports for the Synthesis of Oligonucleotides Containing 3'-Hydroxyl Termini.

Authors:  Hariharan Venkatesan; Marc M. Greenberg
Journal:  J Org Chem       Date:  1996-01-26       Impact factor: 4.354

4.  CRISPR-Cas9: Prospects and Challenges.

Authors:  Feng Zhang
Journal:  Hum Gene Ther       Date:  2015-07       Impact factor: 5.695

5.  Metal-catalyzed one-pot synthesis of tetrazines directly from aliphatic nitriles and hydrazine.

Authors:  Jun Yang; Mark R Karver; Weilong Li; Swagat Sahu; Neal K Devaraj
Journal:  Angew Chem Int Ed Engl       Date:  2012-04-18       Impact factor: 15.336

6.  Partial DNA-guided Cas9 enables genome editing with reduced off-target activity.

Authors:  Hao Yin; Chun-Qing Song; Sneha Suresh; Suet-Yan Kwan; Qiongqiong Wu; Stephen Walsh; Junmei Ding; Roman L Bogorad; Lihua Julie Zhu; Scot A Wolfe; Victor Koteliansky; Wen Xue; Robert Langer; Daniel G Anderson
Journal:  Nat Chem Biol       Date:  2018-01-29       Impact factor: 15.040

7.  Solid-Phase Purification of Synthetic DNA Sequences.

Authors:  Andrzej Grajkowski; Jacek Cieslak; Serge L Beaucage
Journal:  J Org Chem       Date:  2016-07-25       Impact factor: 4.354

8.  A photochemical synthesis of functionalized trans-cyclooctenes driven by metal complexation.

Authors:  Maksim Royzen; Glenn P A Yap; Joseph M Fox
Journal:  J Am Chem Soc       Date:  2008-03-06       Impact factor: 15.419

9.  An artificial triazole backbone linkage provides a split-and-click strategy to bioactive chemically modified CRISPR sgRNA.

Authors:  Lapatrada Taemaitree; Arun Shivalingam; Afaf H El-Sagheer; Tom Brown
Journal:  Nat Commun       Date:  2019-04-08       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.